BioLineRx Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $31.8M | $5.8M |
| FY2015 | — | $47.6M | $5.5M |
| FY2016 | — | $35.0M | $2.5M |
| FY2017 | — | $52.9M | $5.1M |
| FY2018 | — | $41.3M | $3.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $31.8M | $5.8M |
| FY2015 | — | $47.6M | $5.5M |
| FY2016 | — | $35.0M | $2.5M |
| FY2017 | — | $52.9M | $5.1M |
| FY2018 | — | $41.3M | $3.4M |